Lawrence T. Goodnough

Universal leukoreduction of cellular blood components in 2001? No.

L. Goodnough, Lawrence T. Goodnough, 2001, American journal of clinical pathology.

Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.

G. Patterson, E. Trulock, L. Goodnough, 2002, The Journal of thoracic and cardiovascular surgery.

Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.

E. Spitznagel, L. Goodnough, G. Despotis, 1996, The Annals of thoracic surgery.

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.

E. Spitznagel, S. Santoro, L. Goodnough, 1994, The Journal of thoracic and cardiovascular surgery.

In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients.

S. Santoro, L. Goodnough, G. Despotis, 1994, Anesthesia and analgesia.

Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone

R. Vij, M. Tomasson, K. Trinkaus, 2005, Bone Marrow Transplantation.

Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality.

R. Vij, J. Dipersio, D. Adkins, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin

R. Vij, K. Trinkaus, P. Westervelt, 2001, Bone Marrow Transplantation.